|
| |
| | | 67285 | | 28.05.2020 | | Sandoz Pharmaceuticals AG | | | | | | | 27.05.2025 | | | | | | | | | | 07.15. | | |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Dailiport 0.5 mg | Retardkapseln | Delayed release capsules (Tacrolimus 0.5 mg) | L04AD02 | | | 02 | Dailiport 1 mg | Retardkapseln | Delayed release capsules (Tacrolimus 1 mg) | L04AD02 | | | 03 | Dailiport 2 mg | Retardkapseln | Delayed release capsules (Tacrolimus 2 mg) | L04AD02 | | | 04 | Dailiport 3 mg | Retardkapseln | Delayed release capsules (Tacrolimus 3 mg) | L04AD02 | | | 05 | Dailiport 5 mg | Retardkapseln | Delayed release capsules (Tacrolimus 5 mg) | L04AD02 | |
|
|
|
